Potential risks include: Enhanced gastrointestinal side effects (nausea, vomiting, diarrhea, constipation) Increased risk of nutritional deficiencies and protein malnutrition Potential worsening of gastroesophageal reflux symptoms Dehydration risk and acute kidney injury, particularly during dose escalation Increased risk of gallbladder disease and complications Risk of intestinal obstruction or ileus Diabetic retinopathy progression in patients with diabetes, particularly with rapid glycemic improvement Hypoglycemia risk, particularly in patients on insulin or sulfonylureas Cost considerations and insurance coverage challenges Rare but serious risks including pancreatitis and thyroid C-cell tumors (boxed warning) Clinicians must engage in shared decision-making with patients, carefully weighing these potential benefits against risks in the context of individual patient circumstances, surgical outcomes, comorbidities, and treatment goals

Sullivan LB, Gui DY, Hosios AM, Bush LN, Freinkman E, Vander Heiden MG
Each refrigeration unit has its own temperature sensor, all connected to a centralized monitoring system
As of June 2026, there is also an oral version of semaglutide, the Wegovy pill, which is covered further down this page
Vishy Tirupattur: So private credit, this relaxation that you mentioned, you know, a few weeks ago, the FDIC and the OCC withdrew the leveraged lending guidelines in total
The three-dimensional model of the crystal structure of human G6PD shows that the G6PD monomer is built up by two domains, a N-terminal domain and a large + domain with an antiparallel nine-stranded sheet